3 Results Found

Advanced Search

Select all

Results per page

Select all

Article

2 Citations

7,292 Views

14 Pages

Influence of Lisdexamfetamine Dimesylate on Early Ejaculation—Results from a Double-Blind Randomized Clinical Trial

Mohammad Haghighi,
Mona Doostizadeh,
Leila Jahangard,
Alireza Soltanian,
Mohammad Faryadres,
Kenneth M. Dürsteler,
Annette Beatrix Brühl,
Dena Sadeghi-Bahmani and
Serge Brand

Healthcare2021, 9(7), 859;https://doi.org/10.3390/healthcare9070859

-

7 July 2021

Background: Among male sexual dysfunctions, erectile dysfunction and early ejaculation have the highest prevalence rates. Here, we tested the influence of lisdexamfetamine dimesylate (Vyas®) on early ejaculation. To this end, we performed a double-bl...

Full Article

Article

3 Citations

8,470 Views

16 Pages

Identification, Characterization and Quantification of Process-Related and Degradation Impurities in Lisdexamfetamine Dimesylate: Identifiction of Two New Compounds

Shenghua Gao,
Lili Meng,
Chunjie Zhao,
Tao Zhang,
Pengcheng Qiu and
Fuli Zhang

Molecules2018, 23(12), 3125;https://doi.org/10.3390/molecules23123125

-

29 November 2018

Twelve impurities (process-related and degradation) in lisdexamfetamine dimesylate (LDX), a central nervous system (CNS) stimulant drug, were first separated and quantified by high-performance liquid chromatography (HPLC) and then identified by liqui...

Full Article

Article

4 Citations

5,391 Views

16 Pages

Traumatic Brain Injury-Related Attention Deficits in Children: A Controlled Treatment Trial with Lisdexamfetamine Dimesylate (Vyvanse)

Michael G. Tramontana,
Jonathan W. Prokop,
Edwin Williamson,
Tara Duffie and
Hayden LaFever

Brain Sci.2021, 11(1), 117;https://doi.org/10.3390/brainsci11010117

-

16 January 2021

Attention deficits are among the most common and persistent impairments resulting from traumatic brain injury (TBI). This study was the first to examine the effects of lisdexamfetamine dimesylate (LDX, Vyvanse) in treating TBI-related attention defic...

Full Article